Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Andong National University Industry-Academic Cooperation Foundation maintains a company patent portfolio in the Biotechnology and Pharmaceuticals technology area. The portfolio currently features 6 pending office actions. These matters are distributed among 6 distinct examiners, which indicates that the university is engaging with a wide variety of perspectives at the patent office.
The prosecution work is divided across 3 distinct art units. This suggests that the university's research and development efforts in biotechnology are categorized into several different technical specializations. The busiest examiner, BLUMEL, BENJAMIN P, is currently overseeing 1 pending office action. This shows that the 6 pending office actions are spread thinly across the available examiners.
For those managing this portfolio, the presence of 6 distinct examiners means that prosecution strategies must be individualized for each case. Coordination across the 3 distinct art units is also vital to maintain a cohesive intellectual property strategy. Because the busiest examiner pending count is 1, no single examiner dominates the current prosecution landscape for the university.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (50%) |
| §103 only | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLUMEL, BENJAMIN P | 1 | 70.8% | +30.5% |
| SPAINE, ROBERT FRANKLIN | 1 | 75.0% | +0.0% |
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
| MOREAU, NASHARA LOUISE | 1 | 80.0% | -100.0% |
| KARUNASENA, ENUSHA | 1 | 0.0% | +0.0% |
| CHEN, CATHERYNE | 1 | 37.4% | +18.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18544358 | COMPOSITION INCLUDING PROPOLIS AND SORBUS COMMIXTA AS ACTIVE INGREDIENTS FOR ALLEVIATING AND TREATING INFLAMMATORY DISEASES AND ALLERGIC DISEASES | MOREAU, NASHARA LOUISE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18485314 | NOVEL BACILLUS VELEZENSIS GYUN-1190 STRAIN AND USE THEREOF | KARUNASENA, ENUSHA | 19d overdue |
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 50d |
| 18611577 | DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS | BLUMEL, BENJAMIN P | — |
| 18594709 | ANTI-OBESITY COMPOSITION CONTAINING HEMP SEED EXTRACT AS ACTIVE INGREDIENT | SPAINE, ROBERT FRANKLIN | — |
| 18588681 | CONTACT PHEROMONE-CONTAINING COMPOSITION FOR CONTROLLING THRIPS, KIT COMPOSITION FOR CONTROLLING THRIPS, AND METHOD OF CONTROLLING THRIPS BY USING SAME | GONZALEZ, LUISALBERTO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 50d |
| 18611577 | DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS | BLUMEL, BENJAMIN P | — |
| 18588681 | CONTACT PHEROMONE-CONTAINING COMPOSITION FOR CONTROLLING THRIPS, KIT COMPOSITION FOR CONTROLLING THRIPS, AND METHOD OF CONTROLLING THRIPS BY USING SAME | GONZALEZ, LUISALBERTO | — |
| Art Unit | Apps |
|---|---|
| 1655 | 3 |
| 1624 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18611577 | DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS | BLUMEL, BENJAMIN P | — | §101§102§103§112 | Final Rejection | — | Pending | Mar 20, 2024 |
| 18594709 | ANTI-OBESITY COMPOSITION CONTAINING HEMP SEED EXTRACT AS ACTIVE INGREDIENT | SPAINE, ROBERT FRANKLIN | 1655 | §103§112Other | Final Rejection | — | Pending | Mar 04, 2024 |
| 18588681 | CONTACT PHEROMONE-CONTAINING COMPOSITION FOR CONTROLLING THRIPS, KIT COMPOSITION FOR CONTROLLING THRIPS, AND METHOD OF CONTROLLING THRIPS BY USING SAME | GONZALEZ, LUISALBERTO | 1624 | §103§112 | Final Rejection | — | Pending | Feb 27, 2024 |
| 18544358 | COMPOSITION INCLUDING PROPOLIS AND SORBUS COMMIXTA AS ACTIVE INGREDIENTS FOR ALLEVIATING AND TREATING INFLAMMATORY DISEASES AND ALLERGIC DISEASES | MOREAU, NASHARA LOUISE | 1655 | §103 | Final Rejection | — | Pending | Dec 18, 2023 |
| 18485314 | NOVEL BACILLUS VELEZENSIS GYUN-1190 STRAIN AND USE THEREOF | KARUNASENA, ENUSHA | 1653 | §101§102§103§112 | Non-Final OA | 19d overdue | Pending | Oct 12, 2023 |
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 1655 | §101§102§103 | Final Rejection | 50d | Pending | Feb 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial